AMPILI JAGAN: Open Payments
NPI 1346620184 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 5 payments from 4 companies in 2025. Trend: 2023 $243 · 2024 $209 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $232 |
| Abbott Laboratories | 1 | $139 |
| Corcept Therapeutics | 1 | $135 |
| Grifols USA, LLC | 1 | $116 |
Products named: JARDIANCE, FREESTYLE LIBRE 3, Korlym, Prolastin-C Liquid.
Industry payments across TX — which companies pay providers there.
